![Jane Elizabeth Dancer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jane Elizabeth Dancer
Presidente en Pharmenable Ltd. .
Origen de la red de primer grado Jane Elizabeth Dancer.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Pharmenable Ltd.
![]() Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Macomics Ltd.
![]() Macomics Ltd. Miscellaneous Commercial ServicesCommercial Services Macomics Ltd. engages in research and experimental development on biotechnology. The company was founded by Jeffrey William Pollard and Luca Cassetta on November 6, 2018 and is headquartered in Edinburgh, the United Kingdom.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
NanoSyrinx Ltd
![]() NanoSyrinx Ltd Miscellaneous Commercial ServicesCommercial Services NanoSyrinx Ltd is a discovery stage biotechnology company that is based in the UK. The British company is focused on developing protein nanosyringes as a new way to deliver protein and peptide biologic drugs intracellularly. The company uses synthetic biology approaches to achieve this goal. The company was founded by Joseph Healey, Alexia Hapeshi, and Nicholas Waterfield, with Joseph Healey serving as the CEO since incorporation.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Elasmogen Ltd.
![]() Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Elasmogen Ltd. develops soloMER products for treatment of auto-immune mediated and inflammatory diseases. The company is headquartered in Aberdeen, the United Kingdom.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Spirea Ltd.
![]() Spirea Ltd. BiotechnologyHealth Technology Spirea Ltd. operates as a healthcare technology company. It develops smart polymer platform for the controlled delivery of drug combinations to maximise the clinical impact of medicines. The company was founded by Myriam Ouberai and is headquartered in arrogate, the United Kingdom.
3
| Holding Company | Biotechnology | 3 |
AgrEvo GmbH
![]() AgrEvo GmbH Chemicals: AgriculturalProcess Industries AgrEvo GmbH manufacturers fertilizer products. It offers crop protection and production products including seeds, pest control products and other bio- technology products. The company is headquartered in Berlin, Germany.
1
| Private Company | Chemicals: Agricultural | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Jane Elizabeth Dancer a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Private Equity Investor | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Warwick Business School | College/University | Masters Business Admin | |
Cardioxyl Pharmaceuticals LLC
![]() Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Pharmaceuticals: Major | Director/Board Member | |
University of Oxford | College/University | Doctorate Degree Doctorate Degree | |
University of Aberdeen | College/University | Corporate Officer/Principal Graduate Degree | |
University of Cambridge | College/University | Corporate Officer/Principal Doctorate Degree | |
Atlas Venture Advisors, Inc.
![]() Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Analyst | |
GlaxoSmithKline, Inc.
![]() GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cambridge Biotechnology Ltd.
![]() Cambridge Biotechnology Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Biotechnology Ltd. is a wholly owned subsidiary of Biovitrum AB. The company's founders originate from a Pfizer Global Research & Development drug discovery team in what had previously been the Parke-Davis Neuroscience Research Centre. The founders, together with some key academic collaborators, created the company to exploit several opportunities in drug discovery as well as their world class 'gene to lead' drug discovery capability. The company has well equipped modern laboratory and office facilities situated on the Babraham Research Campus. This location allows the company to forge links with a host of world class research groups based in the Cambridge area. CBT is always looking to identify potential partner companies for both in-licensing and risk-sharing drug discovery ventures. | Miscellaneous Commercial Services | Founder | |
ABLYNX | Biotechnology | Corporate Officer/Principal | |
Domain Therapeutics SA
![]() Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Biotechnology | Chief Executive Officer | |
The University of Nottingham | College/University | Undergraduate Degree | |
NeuroSolutions Ltd.
![]() NeuroSolutions Ltd. Miscellaneous Commercial ServicesCommercial Services NeuroSolutions Ltd. provides flexible and skilled services to biopharmaceutical companies with a fast turnaround time. The private company is based in Coventry, UK. The British company has a large portfolio of clients, ranging from small start-ups to multinational pharmaceutical companies, which validates their quality, reliability, speed, and discretion. The company was founded by Kevin Lee. NeuroSolutions was acquired by NeuroSolutions /Private Group/ from OncoSil Medical Ltd. on August 11, 2010 for $0.72 million. | Miscellaneous Commercial Services | Founder | |
ONCOSIL MEDICAL LIMITED | Medical Specialties | Founder | |
Loughborough University | College/University | Masters Business Admin | |
Glasgow Caledonian University | College/University | Doctorate Degree | |
UCB Research, Inc.
![]() UCB Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, UCB Research, Inc. is a company that provides commercial physical research laboratory services. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Cambridge Enterprise Ltd.
![]() Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge. | Investment Managers | Private Equity Investor | |
BioCity Group Ltd
![]() BioCity Group Ltd Investment ManagersFinance BioCity Group Ltd (BioCity) is a venture capital firm founded in 2002. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
BICYCLE THERAPEUTICS PLC | Biotechnology | Chief Executive Officer | |
Business Growth Fund Ltd
![]() Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Ltd (BGF) is private equity firm founded in 2011 by Stephen Welton. The firm is headquartered in the United Kingdom. | Investment Managers | Private Equity Investor | |
Caldan Therapeutics Ltd.
![]() Caldan Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Caldan Therapeutics Ltd. provides novel therapeutics targeting free fatty acid. It focuses on developing drugs in order to deliver anti-diabetic effects in multiple tissues and organs. The company was founded by Graeme Milligan and Trond Ulven and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Oxford Science Enterprises PLC
![]() Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Private Equity Investor | |
STORM Therapeutics Ltd.
![]() STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Z Factor Ltd.
![]() Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom. | Biotechnology | Director/Board Member | |
The University of Glasgow Singapore | College/University | Undergraduate Degree | |
metaLinear Ltd.
![]() metaLinear Ltd. Miscellaneous Commercial ServicesCommercial Services metaLinear Ltd. operates as a biotechnology firm. It uses proteome engineering technology to identify, validate, and drug new microbial targets. The company was founded by Paul Ko Ferrigno in November 2016 and is headquartered in Cheshire, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Fast BioPharma Ltd.
![]() Fast BioPharma Ltd. Miscellaneous Commercial ServicesCommercial Services Fast BioPharma Ltd. develops therapeutic products for treatment of cancer. The company is headquartered in Watlington, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Qkine Ltd.
![]() Qkine Ltd. Pharmaceuticals: OtherHealth Technology Qkine Ltd. provides growth factors and bioactive proteins for use in stem cell science and regenerative medicine applications. Its products include Activin A and FGF2. The firm specializes in protein purification, organoids, cytokines, and protein-engineering. The company was founded by Marko Hyvonen and Catherine Elton in 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
NodThera Ltd.
![]() NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Polyprox Therapeutics Ltd.
![]() Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Polyprox Therapeutics Ltd. operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases. The company was founded by Laura S. Itzhaki in 2018 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
SDS Therapeutics Ltd.
![]() SDS Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services SDS Therapeutics Ltd. is a British biotechnology company founded in 2020 that provides research and development services. The company is based in Cambridge, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Kynos Therapeutics Ltd.
![]() Kynos Therapeutics Ltd. BiotechnologyHealth Technology Kynos Therapeutics Ltd. develops medicines for therapies. The company is based in Edinburgh, UK. The British company was founded by Damian Mole, Scott Webster. The CEO is Jonathan R. Savidge. | Biotechnology | Director/Board Member | |
Azeria Therapeutics Ltd.
![]() Azeria Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Azeria Therapeutics Ltd. engages in the research and development of pharmaceutical products. It develops treatments for hormone resistance that targets breast and prostate cancer patients. The company was founded by Jason Carroll in 2017 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
AlveoGene Ltd.
![]() AlveoGene Ltd. Financial ConglomeratesFinance AlveoGene Ltd. is a British dormant company that was founded in 2022. The company is based in Oxford, UK. | Financial Conglomerates | Director/Board Member | |
Alethiomics Ltd.
![]() Alethiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Alethiomics Ltd. operates as a British biotechnology company. The company is based in Cambridge, UK. The company was founded in 2021 by Adam Joseph Mead, Bethan Psaila. The CEO is Mark Throsby. | Miscellaneous Commercial Services | Director/Board Member | |
We Are Pioneer Group Ltd.
![]() We Are Pioneer Group Ltd. Investment ManagersFinance We Are Pioneer Group Ltd. (Pioneer Group) is a venture capital firm founded in 2021. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Kinomica Ltd.
![]() Kinomica Ltd. BiotechnologyHealth Technology Kinomica Ltd. develops anti-cancer drug therapies. The company is based in Macclesfield, UK. The British company was founded in 2016 by David Britton, Pedro Rodriguez Cutillas. The CEO is Jane Theaker. | Biotechnology | Director/Board Member | |
Dark Blue Therapeutics Ltd.
![]() Dark Blue Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Dark Blue Therapeutics Ltd. operates as a biotechnology firm. The company was founded in June 4, 2020 an is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Rinri Therapeutics Ltd.
![]() Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Rinri Therapeutics Ltd. operates as a biotechnology company developing a novel cell-based therapy to restore hearing. The company was founded in 2018 and is headquartered in Sheffield, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Alchemab Therapeutics Ltd.
![]() Alchemab Therapeutics Ltd. BiotechnologyHealth Technology Alchemab Therapeutics Ltd. engages in developing of antibodies. It focuses on discovering and developing novel therapeutics for patients. The company was founded in 2019 and is headquartered in Kings Cross, the Unite Kingdom. | Biotechnology | Director/Board Member |
Estadísticas
Internacional
Reino Unido | 36 |
Estados Unidos | 8 |
Canadá | 2 |
Bélgica | 2 |
Francia | 2 |
Sectorial
Health Technology | 24 |
Commercial Services | 10 |
Consumer Services | 9 |
Finance | 8 |
Operativa
Director/Board Member | 72 |
Corporate Officer/Principal | 24 |
Founder | 21 |
Chief Executive Officer | 11 |
Private Equity Investor | 9 |
Las relaciones más conectadas
Insiders | |
---|---|
Savvas Neophytou | 24 |
Claire Brown | 17 |
Elizabeth Ann Roper | 16 |
Kevin Lee | 14 |
Jeffrey Moore | 13 |
Christine Martin | 11 |
Andrew Justin Radcliffe Porter | 8 |
Anthony G. Johnson | 6 |
Malcolm Devine | 4 |
Keith Barclay | 3 |
Luca Cassetta | 2 |
Steve Myatt | 2 |
Adam Collier | 2 |
Jelena Aleksic | 2 |
Caroline Barelle | 1 |
- Bolsa de valores
- Insiders
- Jane Elizabeth Dancer
- Conexiones Empresas